Triazine–benzimidazole hybrids: Anticancer activity, DNA interaction and dihydrofolate reductase inhibitors

Viegas-Junior, 2007, Curr. Med. Chem., 14, 1829, 10.2174/092986707781058805 Saczewski, 2006, Eur. J. Med. Chem., 41, 219, 10.1016/j.ejmech.2005.10.013 Agarwal, 2005, Bioorg. Med. Chem. Lett., 15, 531, 10.1016/j.bmcl.2004.11.052 Solankee, 2010, Eur. J. Med. Chem., 45, 510, 10.1016/j.ejmech.2009.10.037 Patel, 2012, Fut. Med. Chem., 4, 1053, 10.4155/fmc.12.57 Zacharie, 2010, J. Med. Chem., 53, 1138, 10.1021/jm901403r Singla, 2014, RSC Adv., 4, 12422, 10.1039/c3ra46304d Yong, 2010, Bioorg. Med. Chem., 18, 4310, 10.1016/j.bmc.2010.04.091 Todorovic, 2007, Chem. Biol. Drug Des., 69, 338, 10.1111/j.1747-0285.2007.00511.x Hasegawa, 2007, J. Med. Chem., 50, 4453, 10.1021/jm0611051 Mackenzie, 2003, Bioorg. Med. Chem. Lett., 13, 2211, 10.1016/S0960-894X(03)00343-3 Selcen, 2009, J. Enzyme Inhib. Med. Chem., 24, 844, 10.1080/14756360802420831 Alper, 2003, Farmaco, 58, 497, 10.1016/S0014-827X(03)00042-9 Selcen, 2009, Med. Chem., 24, 844 Hirashima, 2006, J. Med. Chem., 49, 4721, 10.1021/jm060269e Manohar, 2014, RSC Adv., 4, 7062, 10.1039/c3ra45333b Kumar, 2010, Eur. J. Med. Chem., 45, 2265, 10.1016/j.ejmech.2010.02.001 Baindur, 2005, J. Med. Chem., 48, 1717, 10.1021/jm049372z Grever, 1992, Semin. Oncol., 19, 622 Monks, 1991, J. Natl. Cancer Inst., 83, 757, 10.1093/jnci/83.11.757 Boyd, 1995, Drug Dev. Res., 34, 91, 10.1002/ddr.430340203 Brzozowski, 2000, Eur. J. Med. Chem., 35, 1053, 10.1016/S0223-5234(00)01194-6 Elzahabi, 2011, Eur. J. Med. Chem., 46, 4025, 10.1016/j.ejmech.2011.05.075 Denny, 1990, J. Med. Chem., 33, 814, 10.1021/jm00164a054 Tsitsa, 1993, Eur. J. Med. Chem., 28, 149, 10.1016/0223-5234(93)90007-2 Banerjee, 2013, Chem. Soc. Rev., 42, 1601, 10.1039/c2cs35467e Mudasir, 2010, Spectrochim. Acta, Part A, 77, 528, 10.1016/j.saa.2010.06.032 Lando, 2013, Phys. Math. Sci., 3, 57 Benesi, 1949, J. Am. Chem. Soc., 71, 2703, 10.1021/ja01176a030 Gangjee, 2009, J. Med. Chem., 52, 4892, 10.1021/jm900490a